The genetic basis of resistance to HIV infection and disease progression
暂无分享,去创建一个
[1] K. Shianna,et al. Host genetics of HIV acquisition and viral control. , 2013, Annual review of medicine.
[2] T. Naoe,et al. Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency , 2012, AIDS Research and Therapy.
[3] Kuan-Teh Jeang,et al. MicroRNAs and HIV-1: Complex Interactions* , 2012, The Journal of Biological Chemistry.
[4] Kuan-Teh Jeang,et al. The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1 , 2012, Nucleic acids research.
[5] C. Wachihi,et al. A Genetic Polymorphism of FREM1 Is Associated with Resistance against HIV Infection in the Pumwani Sex Worker Cohort , 2012, Journal of Virology.
[6] Ren-Rong Tian,et al. Translation of Pur‐α is targeted by cellular miRNAs to modulate the differentiation‐dependent susceptibility of monocytes to HIV‐1 infection , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] L. Lopalco,et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. , 2012, Blood.
[8] Hong-Sheng Zhang,et al. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1. , 2012, Biochimica et biophysica acta.
[9] A. Telenti,et al. Host genes important to HIV replication and evolution. , 2012, Cold Spring Harbor perspectives in medicine.
[10] O. Delaneau,et al. Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. , 2012, The Journal of infectious diseases.
[11] E. Campbell,et al. The Cell Biology of TRIM5α , 2012, Current HIV/AIDS Reports.
[12] A. Hill,et al. Human genetic susceptibility to infectious disease , 2012, Nature Reviews Genetics.
[13] G. Boucher,et al. Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State , 2012, PloS one.
[14] M. Clerici,et al. A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection , 2012, The Journal of Immunology.
[15] J. Clements,et al. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients , 2012, Retrovirology.
[16] Andrew P. Rice,et al. Regulation of Cyclin T1 and HIV-1 Replication by MicroRNAs in Resting CD4+ T Lymphocytes , 2011, Journal of Virology.
[17] K. Shianna,et al. Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure , 2011, PloS one.
[18] J. Neefjes,et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.
[19] N. Bresolin,et al. A POSITIVELY SELECTED APOBEC3H HAPLOTYPE IS ASSOCIATED WITH NATURAL RESISTANCE TO HIV‐1 INFECTION , 2011, Evolution; international journal of organic evolution.
[20] Guihua Sun,et al. MicroRNAs and their potential involvement in HIV infection. , 2011, Trends in pharmacological sciences.
[21] K. Shianna,et al. Copy Number Variation of KIR Genes Influences HIV-1 Control , 2011, PLoS biology.
[22] M. Nair,et al. MicroRNA: implications in HIV, a brief overview , 2011, Journal of NeuroVirology.
[23] O. Delaneau,et al. Genome-Wide Association Scan in HIV-1-Infected Individuals Identifying Variants Influencing Disease Course , 2011, PloS one.
[24] J. Turpin,et al. Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals. , 2011, AIDS research and human retroviruses.
[25] S. Khakoo,et al. KIR/HLA Interactions and Pathogen Immunity , 2011, Journal of biomedicine & biotechnology.
[26] R. Maserati,et al. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. , 2011, The Journal of infectious diseases.
[27] Jacques Fellay,et al. Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages , 2011, PloS one.
[28] K. Shianna,et al. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population , 2011, AIDS.
[29] Jack T Stapleton,et al. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.
[30] N. Bresolin,et al. Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection. , 2010, Human molecular genetics.
[31] C. Wachihi,et al. HIV‐exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV‐dependent host factors. , 2010, The Journal of infectious diseases.
[32] Warren W. Kretzschmar,et al. Balancing Selection Maintains a Form of ERAP2 that Undergoes Nonsense-Mediated Decay and Affects Antigen Presentation , 2010, PLoS genetics.
[33] O. Delaneau,et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. , 2010, The Journal of infectious diseases.
[34] K. Shianna,et al. Host determinants of HIV-1 control in African Americans. , 2010, The Journal of infectious diseases.
[35] C. Winkler,et al. Host genes associated with HIV/AIDS: advances in gene discovery. , 2010, Trends in genetics : TIG.
[36] M. Clerici,et al. TLR Activation Pathways in HIV-1–Exposed Seronegative Individuals , 2010, The Journal of Immunology.
[37] T. Ndung’u,et al. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load , 2010, AIDS.
[38] J. Goedert,et al. HLA-B*35-Px–mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses , 2009, The Journal of experimental medicine.
[39] E. Thiel,et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.
[40] P. Hunt. Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes. , 2009, The Journal of infectious diseases.
[41] J. Blankson,et al. Elucidating the elite: mechanisms of control in HIV-1 infection. , 2009, Trends in pharmacological sciences.
[42] Elizabeth T. Cirulli,et al. Common Genetic Variation and the Control of HIV-1 in Humans , 2009, PLoS genetics.
[43] B. Agan,et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. , 2009, The Journal of infectious diseases.
[44] J. Phair,et al. CCL3L1 and HIV/AIDS susceptibility , 2009, Nature Medicine.
[45] D. Clayton,et al. Experimental aspects of copy number variant assays at CCL3L1 , 2009, Nature Medicine.
[46] T. Nakajima,et al. Impact of novel TRIM5α variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection , 2009, AIDS.
[47] Hong Cao,et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions. , 2009, Molecular cell.
[48] David Burgner,et al. HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.
[49] S. Ross. Are Viruses Inhibited by APOBEC3 Molecules from Their Host Species? , 2009, PLoS pathogens.
[50] G. Reyes-Terán,et al. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression , 2009, Retrovirology.
[51] D. Metzger,et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. , 2009, Blood.
[52] R. Detels. The 'immunologic advantage' of HIV-exposed seronegative individuals , 2009 .
[53] B. Walker,et al. Elite control of HIV infection: implications for vaccine design , 2009, Expert opinion on biological therapy.
[54] M. Clerici,et al. Genetic correlates of protection against HIV infection: the ally within , 2009, Journal of internal medicine.
[55] A. Rice,et al. miR-198 Inhibits HIV-1 Gene Expression and Replication in Monocytes and Its Mechanism of Action Appears To Involve Repression of Cyclin T1 , 2009, PLoS pathogens.
[56] M. Essex,et al. Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.
[57] V. Scaria,et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication , 2008, Retrovirology.
[58] M. Carrington,et al. KIR-HLA intercourse in HIV disease. , 2008, Trends in microbiology.
[59] P. Sharp,et al. Small RNA Regulators of Gene Expression , 2008, Cell.
[60] Philip J. R. Goulder,et al. Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.
[61] Ma Luo,et al. Human Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya , 2008, Journal of Virology.
[62] N. Nagelkerke,et al. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort , 2008, AIDS.
[63] M. Carrington,et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. , 2008, The Journal of infectious diseases.
[64] N. Nagelkerke,et al. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection , 2008, AIDS.
[65] J. Routy,et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals , 2008, AIDS.
[66] Terri Wrin,et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. , 2008, The Journal of infectious diseases.
[67] H. Schuitemaker,et al. The Effect of Trim5 Polymorphisms on the Clinical Course of HIV-1 Infection , 2008, PLoS pathogens.
[68] Jialing Huang,et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.
[69] Todd M. Allen,et al. Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.
[70] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[71] L. Lopalco,et al. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. , 2007, The Journal of infectious diseases.
[72] Hulin Wu,et al. APOBEC3G levels predict rates of progression to AIDS , 2007, Retrovirology.
[73] Pascal Barbry,et al. Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication , 2007, Science.
[74] S. S. Chauhan,et al. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[75] L. Elviri,et al. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. , 2007, Blood.
[76] B. Vuylsteke,et al. Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands1 , 2006, The Journal of Immunology.
[77] Roger Detels,et al. Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection , 2006 .
[78] M. Alary,et al. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians , 2006, AIDS.
[79] Christos J. Petropoulos,et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus , 2006, The Journal of experimental medicine.
[80] John Bui,et al. Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.
[81] S. Rowland-Jones,et al. Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev , 2006, AIDS.
[82] Vinod Scaria,et al. Targets for human encoded microRNAs in HIV genes. , 2005, Biochemical and biophysical research communications.
[83] S. Hunt,et al. Genome-Wide Associations of Gene Expression Variation in Humans , 2005, PLoS genetics.
[84] L. Meyer,et al. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters , 2005, AIDS.
[85] Mario Clerici,et al. Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians , 2005, AIDS.
[86] B. Rovin,et al. The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .
[87] V. Kim,et al. The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.
[88] Amalio Telenti,et al. APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS , 2004, Journal of Virology.
[89] Stephen J O'Brien,et al. Human genes that limit AIDS , 2004, Nature Genetics.
[90] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[91] Todd M. Allen,et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection , 2003, AIDS.
[92] Stephen J O'Brien,et al. The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.
[93] N. Saksena,et al. Mechanisms involved in non-progressive HIV disease. , 2003, AIDS reviews.
[94] T. Hodge,et al. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand. , 2003, AIDS research and human retroviruses.
[95] M. Lejeune,et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. , 2002, The Journal of infectious diseases.
[96] Tao Dong,et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.
[97] Y. Takebe,et al. Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 64I homozygosity with HIV-1-negative status. , 2002, Journal of acquired immune deficiency syndromes.
[98] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[99] Edward C. Holmes,et al. Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[100] S. Rowland-Jones,et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.
[101] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[102] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[103] S. H. van der Burg,et al. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. , 1998, The Journal of general virology.
[104] J. Mills,et al. HIV‐1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV‐1‐infected individuals , 1998, AIDS.
[105] N. Nagelkerke,et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. , 1998, The Journal of infectious diseases.
[106] C. Mackay,et al. Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding , 1997, The Journal of experimental medicine.
[107] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[108] R. Phillips,et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.
[109] N. Nagelkerke,et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.
[110] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[111] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[112] J. Berzofsky,et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. , 1992, The Journal of infectious diseases.
[113] Steven M. Wolinsky,et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. , 1989, The New England journal of medicine.
[114] N. Nagelkerke,et al. Heterogeneity in susceptibility to HIV-1 in continuously exposed prostitutes. , 1992 .
[115] A. Fauci,et al. The immunopathogenesis of HIV infection. , 1989, Advances in immunology.